Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine XR response predictors in schizophrenia
2009-013028-21Phase 4Terminated
- Sponsor
- Policlinico di Bari
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of quetiapine in schizophrenia, sponsored by Policlinico di Bari. Primary endpoint: Change from baseline in PANSS score by BDNF genotype after quetiapine XR treatment. Started Sep 2010; status: terminated.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2009-013028-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013028-21.